Gian Lifecare Ltd (GIANLIFE) is currently trading at 7.98 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Gian Life Care Limited is primarily engaged in providing diagnostic and healthcare tests, operating major labs in Kanpur and Lucknow. Established in 1995, Gian Pathology has evolved into a large diagnostic center under the leadership of Arun Kumar Gupta. The company offers a wide range of approximately 1,344 diagnostic tests in multiple disciplines including molecular biology. Gian Life Care expanded through an IPO, issuing over 1.4 million equity shares, raising Rs 3.11 Crore. Plans are underway to set up more diagnostic labs across various regions, indicating growth ambitions.

Over the past 52 weeks, Gian Lifecare Ltd has traded between a low of ₹7.08 and a high of ₹20.50. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Gian Lifecare Ltd has a market capitalization of approximately 8.04. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Gian Lifecare Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of -8.49 and operates in the Healthcare sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 8.04 Cr, Gian Lifecare Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Gian Lifecare Ltd operates in the Healthcare sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Gian Lifecare Ltd is -8.49. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.